Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
about
Vaccines against drugs of abuse: where are we now?Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alumBiologics to treat substance use disorders: Current status and new directionsThe effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines.Current status and future prospects for the development of substance abuse vaccines.Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
P2860
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Suppression of nicotine-induce ...... on-based antinicotine vaccine.
@en
type
label
Suppression of nicotine-induce ...... on-based antinicotine vaccine.
@en
prefLabel
Suppression of nicotine-induce ...... on-based antinicotine vaccine.
@en
P2093
P2860
P356
P1433
P1476
Suppression of nicotine-induce ...... on-based antinicotine vaccine.
@en
P2093
Bishnu P De
Jonathan B Rosenberg
Kim D Janda
Martin J Hicks
Ronald G Crystal
Stefan Worgall
Stephen M Kaminsky
P2860
P304
P356
10.1089/HUM.2012.245
P577
2013-06-01T00:00:00Z